Skip to main content
Top
Published in: Journal of Nuclear Cardiology 2/2017

01-04-2017 | Editorial

Cardiac sarcoidosis: An important niche for PET, but a journey just begun

Author: Timothy M. Bateman, MD, MASNC

Published in: Journal of Nuclear Cardiology | Issue 2/2017

Login to get access

Excerpt

Heart failure! From the victim’s perspective, the diagnosis has evolved to be as feared as cancer. It is a life-changing diagnosis, a formidable enemy, often a drawn-out “death sentence”. It affects quality of life, life expectancy, family finances, compliance with multiple medications often taken 2 or 3 times per day, consideration of hardware implants, and frequent tests to help determine etiology and assess response to interventions. From a cardiology practice perspective, heart failure has become a major focus of attention. In the United States alone, some 5.7 million people have heart failure, with approximately 550,000 new cases diagnosed each year. The cost of caring for people with heart failure exceeds $30 billion annually.1 It should not be surprising that heart failure has become as important a focus for cardiologists in the twenty-first century as coronary artery disease was in the late twentieth century. …
Literature
1.
go back to reference Mozzafarian D, Benjamin EJ, Go AS, American Heart Association Statistics Committee, Stroke Statistics Subcommittee, et al. Heart disease and stroke statistics—2016 update: A report from the American Heart Association. Circulation. 2016;133:e38–360.CrossRef Mozzafarian D, Benjamin EJ, Go AS, American Heart Association Statistics Committee, Stroke Statistics Subcommittee, et al. Heart disease and stroke statistics—2016 update: A report from the American Heart Association. Circulation. 2016;133:e38–360.CrossRef
2.
go back to reference Bateman TM. Twelfth annual Mario S. Verani, MD memorial lecture: Vision, leadership, and change—A reflection on the challenges and opportunities in the community-based practice of nuclear cardiology. J Nucl Cardiol. 2015;22:435–49.CrossRefPubMed Bateman TM. Twelfth annual Mario S. Verani, MD memorial lecture: Vision, leadership, and change—A reflection on the challenges and opportunities in the community-based practice of nuclear cardiology. J Nucl Cardiol. 2015;22:435–49.CrossRefPubMed
3.
go back to reference Ahmadian A, Pawar S, Govender P, et al. The response of FDG uptake to immunosuppressive treatment on FDG PET/CT imaging for cardiac sarcoidosis. J Nucl Cardiol 2016 (in press) Ahmadian A, Pawar S, Govender P, et al. The response of FDG uptake to immunosuppressive treatment on FDG PET/CT imaging for cardiac sarcoidosis. J Nucl Cardiol 2016 (in press)
4.
go back to reference Iwai K, Takemura T, Kitaichi M, et al. Pathological studies on sarcoidosis autopsy. II. Early change, mode of progression and death pattern. Acta Pathol Jpn. 1993;43:377–85.PubMed Iwai K, Takemura T, Kitaichi M, et al. Pathological studies on sarcoidosis autopsy. II. Early change, mode of progression and death pattern. Acta Pathol Jpn. 1993;43:377–85.PubMed
5.
go back to reference Birnie DH, Sauer WH, Bogun F, et al. HRS expert consensus statement on the diagnosis and management of arrhythmias associated with cardiac sarcoidosis. Heart Rhythm. 2014;11:1305–23.CrossRefPubMed Birnie DH, Sauer WH, Bogun F, et al. HRS expert consensus statement on the diagnosis and management of arrhythmias associated with cardiac sarcoidosis. Heart Rhythm. 2014;11:1305–23.CrossRefPubMed
6.
go back to reference Blankstein R, Osborne M, Naya M, Waller A, Kim CK, Murthy VL, et al. Cardiac positron emission tomography enhances prognostic assessments of patients with suspected cardiac sarcoidosis. J Am Coll Cardiol. 2014;21:166–74. Blankstein R, Osborne M, Naya M, Waller A, Kim CK, Murthy VL, et al. Cardiac positron emission tomography enhances prognostic assessments of patients with suspected cardiac sarcoidosis. J Am Coll Cardiol. 2014;21:166–74.
7.
go back to reference Ahmadian A, Brogan A, Berman J, et al. Quantitative interpretation of FDG PET/CT with myocardial perfusion imaging increases diagnostic information in the evaluation of cardiac sarcoidosis. J Nucl Cardiol. 2014;21:925–39.CrossRefPubMed Ahmadian A, Brogan A, Berman J, et al. Quantitative interpretation of FDG PET/CT with myocardial perfusion imaging increases diagnostic information in the evaluation of cardiac sarcoidosis. J Nucl Cardiol. 2014;21:925–39.CrossRefPubMed
8.
go back to reference Kandolin R, Lehtonen J, Airaksinen J, et al. Cardiac sarcoidosis: epidemiology, characteristics, and outcome over 25 years in a nationwide study. Circulation. 2015;131(7):624–32.CrossRefPubMed Kandolin R, Lehtonen J, Airaksinen J, et al. Cardiac sarcoidosis: epidemiology, characteristics, and outcome over 25 years in a nationwide study. Circulation. 2015;131(7):624–32.CrossRefPubMed
9.
go back to reference Waller AH, Blankstein R. Quantifying myocardial inflammation using F-18 fluorodeoxyglucose positron emission tomography in cardiac sarcoidosis. J Nucl Cardiol. 2014;21:940–3.CrossRefPubMed Waller AH, Blankstein R. Quantifying myocardial inflammation using F-18 fluorodeoxyglucose positron emission tomography in cardiac sarcoidosis. J Nucl Cardiol. 2014;21:940–3.CrossRefPubMed
10.
go back to reference Dorbala S, Di Carli MF, Delbeke D, Abbara S, DePuey EG, Dilsizian V, et al. SNMMI/ASNC/SCCT guideline for cardiac SPECT/CT and PET/CT 1.0. J Nucl Med. 2013;54:1485–507.CrossRefPubMed Dorbala S, Di Carli MF, Delbeke D, Abbara S, DePuey EG, Dilsizian V, et al. SNMMI/ASNC/SCCT guideline for cardiac SPECT/CT and PET/CT 1.0. J Nucl Med. 2013;54:1485–507.CrossRefPubMed
11.
go back to reference Osborne MT, Hulten EA, Murthy VL, et al. Patient preparation for cardiac fluorine-18 fluorodeoxyglucose positron emission tomography of inflammation. J Nucl Cardiol. 2016. doi:10.1007/s12350-016-0502-7. Osborne MT, Hulten EA, Murthy VL, et al. Patient preparation for cardiac fluorine-18 fluorodeoxyglucose positron emission tomography of inflammation. J Nucl Cardiol. 2016. doi:10.​1007/​s12350-016-0502-7.
Metadata
Title
Cardiac sarcoidosis: An important niche for PET, but a journey just begun
Author
Timothy M. Bateman, MD, MASNC
Publication date
01-04-2017
Publisher
Springer US
Published in
Journal of Nuclear Cardiology / Issue 2/2017
Print ISSN: 1071-3581
Electronic ISSN: 1532-6551
DOI
https://doi.org/10.1007/s12350-016-0624-y

Other articles of this Issue 2/2017

Journal of Nuclear Cardiology 2/2017 Go to the issue

Nuclear Cardiology in the Literature

A selection of recent, original research papers